Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

212 trials

Showing 20 of 212 results

Testing effectiveness (Phase 2)Study completedNCT03921411
What this trial is testing

A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Galderma R&D 20
Large-scale testing (Phase 3)Study completedNCT05633355
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 187
Not applicableLooking for participantsNCT03936335
What this trial is testing

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

Who this might be right for
Adverse Pregnancy OutcomesAtopic Dermatitis
Regeneron Pharmaceuticals 3,930
Testing effectiveness (Phase 2)Looking for participantsNCT06810050
What this trial is testing

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
CAGE Bio Inc. 180
Early research (Phase 1)Looking for participantsNCT06982352
What this trial is testing

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Who this might be right for
Atopic Dermatitis (AD)Psoriasis (PsO)
LAPIX Therapeutics Inc. 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175233
What this trial is testing

Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu Simcere Pharmaceutical Co., Ltd. 184
Early research (Phase 1)Active Not RecruitingNCT06920693
What this trial is testing

Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants

Who this might be right for
Atopic Dermatitis (AD)
Generate Biomedicines 40
Large-scale testing (Phase 3)Study completedNCT05650320
What this trial is testing

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD

Who this might be right for
Atopic Dermatitis (AD)
Otsuka Beijing Research Institute 240
Testing effectiveness (Phase 2)Study completedNCT07182864
What this trial is testing

MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Minghui Pharmaceutical (Hangzhou) Ltd 160
Testing effectiveness (Phase 2)Study completedNCT03703102
What this trial is testing

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kyowa Kirin, Inc. 274
Not applicableLooking for participantsNCT04170244
What this trial is testing

Skin Microbial Ecology in Atopic Dermatitis

Who this might be right for
Atopic DermatitisPsoriasisHealthy
University of Rochester 240
Not applicableNot Yet RecruitingNCT07333300
What this trial is testing

Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Dermatitis After Application of Marketed Product Compared With Placebo (Water Application).

Who this might be right for
Atopic Dermatitis (AD)
NovoBliss Research Pvt Ltd 20
Post-approval studies (Phase 4)Study completedNCT00121316
What this trial is testing

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

Who this might be right for
Atopic Dermatitis
Novartis 200
Not applicableStudy completedNCT02357940
What this trial is testing

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

Who this might be right for
Atopic Dermatitis (AD)
Johnson & Johnson Consumer Inc. (J&JCI) 41
Not applicableStudy completedNCT03142139
What this trial is testing

Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age?

Who this might be right for
Atopic Dermatitis
Bandim Health Project 1,027,559
Not applicableUnknownNCT04699695
What this trial is testing

A Prospective Sample Collection Study Using Non-invasive Methods to Investigate Biomarkers in AD Patients

Who this might be right for
Atopic Dermatitis
DermTech 500
Not applicableLooking for participantsNCT06238765
What this trial is testing

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

Who this might be right for
Atopic Dermatitis
CorEvitas 1,500
Large-scale testing (Phase 3)Study completedNCT03269773
What this trial is testing

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 197
Large-scale testing (Phase 3)Study completedNCT05398445
What this trial is testing

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

Who this might be right for
Atopic Dermatitis
Amgen 769
Large-scale testing (Phase 3)Active Not RecruitingNCT05882877
What this trial is testing

Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 2,621
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation